Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0Journal of Gastrointestinal Cancer

Incidence of Colorectal Cancer After Endoscopic Mucosal Resection: A Multicenter Electronic Health Record Cohort Study

5 affiliations
  1. 1Department of Internal Medicine, New York Medical College at Saint Michael’s Medical Center, Newark, NJ USA
  2. 2Division of Gastroenterology and Hepatology, West Virginia University, Morgantown, WV USA
  3. 3Department of Medicine, University of Missouri-Columbia, Columbia, MO USA
  4. 4Department of Internal Medicine, Hunt Regional Medical Center, Greenville, TX USA
  5. 5Division of Gastroenterology and Hepatology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY USA

Abstract

Background: Endoscopic mucosal resection (EMR) is widely used for large and complex colorectal lesions and offers a less invasive alternative to surgery. Although adenoma recurrence after EMR has been described in procedural cohorts, real-world estimates of subsequent colorectal cancer (CRC) diagnoses after EMR across multicenter electronic health record (EHR) systems remain limited.

Methods: We conducted a retrospective cohort study using the TriNetX US Collaborative Network. Patients aged 40 years or older who underwent colonoscopy or sigmoidoscopy with EMR between January 1, 2016 and January 1, 2017 were included. Patients with Crohn’s disease, ulcerative colitis, familial adenomatous polyposis, or CRC recorded on or before the index EMR date were excluded. The primary outcome was incident CRC, defined by ICD-10-CM codes C18, C19, and C20, assessed from January 1, 2018 through December 31, 2021 after a one-year washout period. Incidence rates are reported per 1,000 person-years with exact Poisson 95% confidence intervals (CIs). A sensitivity analysis was restricted to patients aged 50–75 years at index EMR.

Results: Among 3,081 eligible patients, the mean age was 62.9 ± 8.89 years and 52% were female; 2,735 were at risk at the start of follow-up. Twenty-two incident CRC diagnoses occurred over 10,187.8 person-years, an incidence of 2.16 per 1,000 person-years (95% CI, 1.35–3.27). Each calendar year contained 10 or fewer events, so annual rates could not be estimated. Incidence was 2.54 (95% CI, 1.31–4.44) in males and 1.83 (95% CI, 0.88–3.36) in females. In the 50-75-year sensitivity cohort, 19 events occurred over 8,894.8 person-years (2.14 per 1,000 person-years; 95% CI, 1.29–3.34). During years 1–5 after index EMR, repeat EMR occurred in 119 patients (3.9%), colorectal surgery in 28 (0.9%), and subsequent colorectal polyp diagnoses in 1,321 (42.9%); no ESD procedures were identified.

Conclusion: CRC diagnoses after EMR were uncommon in this multicenter EHR cohort, occurring at about 2 per 1,000 person-years. Event counts were too small to estimate annual trends or to compare incidence reliably across race and ethnicity groups. Studies linking EHR data to endoscopy and pathology reports are needed to identify preventable cancers after EMR.

Related

  1. Internal traction using a preserved tissue bridge for defect closure during colorectal endoscopic full-thickness resection
    Futao Wu, Siqi Yang, Xiaoying Lu +4
    EndoscopyPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Pre-Resection Endoscopic Features in T1 Colorectal Cancer Selected for Salvage Surgery After ESD/EID: An Exploratory Comparison of SM1 and SM2–3 Invasion
    Kasper Maryńczak, Julia Adamkiewicz, Jacek Kabziński +6
    Journal of clinical medicinePeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  3. Cold snare polypectomy versus conventional endoscopic mucosal resection for colorectal polyps 15 mm or smaller: delayed bleeding and resection outcomes in a retrospective cohort.
    Hyun Young Kim
    BMC gastroenterologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  4. Endoscopic transorbital approach for resection of Meckel’s cave aspergillosis: illustrative case
    Raywat Noiphithak, Krit Khunvirojpanich, Putch Phairintr +1
    Journal of neurosurgery. Case lessonsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Endoscopic closure of refractory perforation after duodenal neuroendocrine tumor resection with multiple strategies
    Fang Xu, Zhao Yan, Chun Li +4
    EndoscopyPeer-reviewedCC BY 4.0Full textOncologyPMC
BibTeX
@article{eldesouki2026incidence,
  title = {{Incidence of Colorectal Cancer After Endoscopic Mucosal Resection: A Multicenter Electronic Health Record Cohort Study}},
  author = {Mohamed H. Eldesouki and Khaled Elfert and EzzElDien A. Ibrahim and Mohammed Y. Youssef and Aasma Shaukat and Shyam Thakkar},
  journal = {Journal of Gastrointestinal Cancer},
  year = {2026},
  month = nov,
  doi = {10.1007/s12029-026-01634-4},
  url = {https://doi.org/10.1007/s12029-026-01634-4},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Incidence of Colorectal Cancer After Endoscopic Mucosal Resection: A Multicenter Electronic Health Record Cohort Study
AU  - Mohamed H. Eldesouki
AU  - Khaled Elfert
AU  - EzzElDien A. Ibrahim
AU  - Mohammed Y. Youssef
AU  - Aasma Shaukat
AU  - Shyam Thakkar
PY  - 2026
DA  - 2026/11/07
JO  - Journal of Gastrointestinal Cancer
DO  - 10.1007/s12029-026-01634-4
UR  - https://doi.org/10.1007/s12029-026-01634-4
AB  - Background: Endoscopic mucosal resection (EMR) is widely used for large and complex colorectal lesions and offers a less invasive alternative to surgery. Although adenoma recurrence after EMR has been described in procedural cohorts, real-world estimates of subsequent colorectal cancer (CRC) diagnoses after EMR across multicenter electronic health record (EHR) systems remain limited.  Methods: We conducted a retrospective cohort study using the TriNetX US Collaborative Network. Patients aged 40 years or older who underwent colonoscopy or sigmoidoscopy with EMR between January 1, 2016 and January 1, 2017 were included. Patients with Crohn’s disease, ulcerative colitis, familial adenomatous polyposis, or CRC recorded on or before the index EMR date were excluded. The primary outcome was incident CRC, defined by ICD-10-CM codes C18, C19, and C20, assessed from January 1, 2018 through December 31, 2021 after a one-year washout period. Incidence rates are reported per 1,000 person-years with exact Poisson 95% confidence intervals (CIs). A sensitivity analysis was restricted to patients aged 50–75 years at index EMR.  Results: Among 3,081 eligible patients, the mean age was 62.9 ± 8.89 years and 52% were female; 2,735 were at risk at the start of follow-up. Twenty-two incident CRC diagnoses occurred over 10,187.8 person-years, an incidence of 2.16 per 1,000 person-years (95% CI, 1.35–3.27). Each calendar year contained 10 or fewer events, so annual rates could not be estimated. Incidence was 2.54 (95% CI, 1.31–4.44) in males and 1.83 (95% CI, 0.88–3.36) in females. In the 50-75-year sensitivity cohort, 19 events occurred over 8,894.8 person-years (2.14 per 1,000 person-years; 95% CI, 1.29–3.34). During years 1–5 after index EMR, repeat EMR occurred in 119 patients (3.9%), colorectal surgery in 28 (0.9%), and subsequent colorectal polyp diagnoses in 1,321 (42.9%); no ESD procedures were identified.  Conclusion: CRC diagnoses after EMR were uncommon in this multicenter EHR cohort, occurring at about 2 per 1,000 person-years. Event counts were too small to estimate annual trends or to compare incidence reliably across race and ethnicity groups. Studies linking EHR data to endoscopy and pathology reports are needed to identify preventable cancers after EMR.
SN  - 1941-6628
SN  - 1941-6636
ER  -